Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Unknown 3Terminated 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Observational 5Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 4Other hematologic neoplasm 1

Conditions

Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Heart Diseases 3Vascular Diseases 2Small Cell Lung Carcinoma 2Leukemia, Myeloid, Acute 2Cardiovascular Diseases 2Cardiotoxicity 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Cancer Resectable 1Ovarian Carcinosarcoma 1Noonan Syndrome 5 1Neoplasms, Second Primary 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Metabolic Diseases 1Liver Neoplasms 1Leukemia, Monocytic, Acute 1Leukemia, Lymphoid 1Immune-related Adverse Event 1Hematologic Neoplasms 1Heart Failure 1Esophageal Neoplasms 1Early Hormone Receptor-positive Breast Cancer 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Neoplasms × Antineoplastic Agents × Clear all
NCT07621289 2026-06-02

EUCARTOXSCORES

University Hospital, Caen

Not yet recruiting
10,000 enrolled
Other hematologic neoplasm

Cardiovascular Diseases, Neoplasms, Hematologic Neoplasms

NCT06877533 2025-08-12

A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors

iTeos Therapeutics

Phase 1 Terminated
3 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06409481 2024-05-10

PARCA

The First Affiliated Hospital of Xinxiang Medical College

Unknown
800,000 enrolled

Cardiovascular Diseases, Heart Diseases, Neoplasms, Vascular Diseases

NCT03530215 2023-04-13

EROCA

Groupe Hospitalier Pitie-Salpetriere

Completed
500,000 enrolled

Heart Diseases, Neoplasms, Cardiotoxicity

NCT05467189 2022-07-20

Antineoplastic Drugs in Elderly Patients

Shandong University

Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT04696250 2021-01-06

AVATAR

University Hospital, Caen

Unknown
5,000,000 enrolled
Tumor-Agnostic

Neoplasms

NCT03777930 2018-12-19

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Shenzhen Fifth People's Hospital

Phase 4 Unknown
200 enrolled
Tumor-Agnostic

Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡